Viteyes visits Ophthalmologists and GP's this week
We emphasise the strong research base behind Viteyes - as this is of high importance to prescribers such as ophthalmologists and GP's. Evidence based prescribing ensures that patients receive the treatments that give the best results - the AREDS2 clinical trial forms the research base for Viteyes.
As well as attending educational lectures, the delegates meet to discuss the latest research and visit the stands from optical suppliers such as ourselves. We also get to meet up with our fellow suppliers to discuss industry trends and to see each others new products.
Delegates from professions allied to ophthalmology attend the Congress and there are sessions for Retina, Glaucoma, Paediatric and GP's. Getting our message out to as many health professionals as possible is crucial as they are in contact with patients who may be at risk of macular degeneration. Our optical and pharmacy backgrounds ensure that we can explain the results and limitations of the research currently available.
The Royal College of Ophthalmologists Scientific Committee work hard on the scientific programme and choose the best speakers in their different fields. These are dynamic internationally renowned lecturers, chosen to address the UK's largest ophthalmic conference and exhibition. The President’s session on the first morning of the Congress, features these internationally renowned speakers.
The Chairman of the Scientific Committee Michael Burdon says 'The eponymous lectures honour the outstanding achievements of previous ophthalmologists and visual scientists, and recognise our links with the ophthalmic industry. We are delighted that equally eminent individuals, Professors Philip Luthert, John Dart, Jay Neitz, Maureen Neitz and Robert Osher, have agreed to deliver this year's lectures.'